Pip and Deb - Amazing Fundraisers

On the 6th August Paul Pipkin (Pip) will be embarking on a 211 mile walk for MS Research. He will start in Whitehaven on the west coast of England and end up at St Mary's lighthouse on the east coast going via the historic Hadrian’s Wall.

Since Pip’s wife Deb was diagnosed with Multiple Sclerosis (MS) 12 years ago they have both become dedicated fundraisers for MS charities and have supported MS Research since 2015 for which we are extremely grateful.

Continue reading

Treatment algorithms for MS - Modifying Therapies

Our chair Dr Rosie Jones shares her thoughts on ‘Treatment Algorithms for Multiple Sclerosis Disease-Modifying Therapies’ (full document here)- an important document recently released by NHS England which updates the current guidance for medical professionals on drugs and other therapeutic approaches in early relapse/remitting MS.

Continue reading

Online Research Survey - Perspectives on Using Cannabis-based Medicines as Treatment for Multiple Sclerosis (MS) in the UK

We have an opportunity for you take part in a short online survey on perspectives towards using cannabis-based medicines as treatment for Multiple Sclerosis in the UK.

The research conducted is by a King’s College London student who aims to investigate views towards the availability and accessibility of cannabis-based medicines such as Sativex in the UK. This is a voluntary questionnaire particularly aimed at family members and carers of those affected by MS.

Continue reading

Why be a Charity Trustee

Our trustees are an integral part of MS Research. They all have personal experience of MS and they very kindly share with us their time, experience and skills in order to steer the charity in the right direction ensuring that we are able to achieve our aims of furthering our understanding of MS, developing better treatments and working towards finding an eventual cure.

We asked four members of our board for their thoughts on why they think being a Trustee for MS Research is important:

Continue reading

new drugs for Relapsing Remitting MS - A comment on benefits and risks

In an article on Multiple Sclerosis News Today Ed Tobias, who has MS, discusses news items on the increasing awareness of possible risks associated with some of the new MS Disease Modifying Drugs (DMDs).

He writes: “…all disease-modifying treatments have the possibility of side effects, and some are more serious than others. We who use the treatments should always be doing so with our eyes wide open and fully informed of the risks.

Continue reading

Cookie Policy

This website uses cookies that are necessary to its functioning and required to achieve the purposes illustrated in the privacy policy. By accepting this OR scrolling this page OR continuing to browse, you agree to our privacy policy.

Registered Charity Number 1043280. Company No. 3005230